Wooree BioLtd Balance Sheet Health
Financial Health criteria checks 6/6
Wooree BioLtd has a total shareholder equity of ₩268.7B and total debt of ₩100.8B, which brings its debt-to-equity ratio to 37.5%. Its total assets and total liabilities are ₩646.0B and ₩377.4B respectively. Wooree BioLtd's EBIT is ₩23.7B making its interest coverage ratio 19.3. It has cash and short-term investments of ₩106.5B.
Key information
37.5%
Debt to equity ratio
₩100.84b
Debt
| Interest coverage ratio | 19.3x |
| Cash | ₩106.55b |
| Equity | ₩268.69b |
| Total liabilities | ₩377.36b |
| Total assets | ₩646.05b |
Recent financial health updates
Does Wooree BioLtd (KOSDAQ:082850) Have A Healthy Balance Sheet?
Dec 16
Is Wooree BioLtd (KOSDAQ:082850) A Risky Investment?
Aug 10These 4 Measures Indicate That Wooree BioLtd (KOSDAQ:082850) Is Using Debt Reasonably Well
May 03Here's Why Wooree BioLtd (KOSDAQ:082850) Can Manage Its Debt Responsibly
Feb 01
Recent updates
Does Wooree BioLtd (KOSDAQ:082850) Have A Healthy Balance Sheet?
Dec 16Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 28%
Oct 23Risks Still Elevated At These Prices As Wooree Bio Co.,Ltd (KOSDAQ:082850) Shares Dive 27%
Sep 07Wooree BioLtd (KOSDAQ:082850) Hasn't Managed To Accelerate Its Returns
Aug 30Is Wooree BioLtd (KOSDAQ:082850) A Risky Investment?
Aug 10Wooree Bio Co.,Ltd's (KOSDAQ:082850) Shares Climb 37% But Its Business Is Yet to Catch Up
Jul 19Wooree BioLtd's (KOSDAQ:082850) Earnings Seem To Be Promising
May 25These 4 Measures Indicate That Wooree BioLtd (KOSDAQ:082850) Is Using Debt Reasonably Well
May 03Wooree Bio Co.,Ltd's (KOSDAQ:082850) Share Price Boosted 50% But Its Business Prospects Need A Lift Too
Apr 26Should You Invest In Wooree BioLtd (KOSDAQ:082850)?
Feb 28Here's Why Wooree BioLtd (KOSDAQ:082850) Can Manage Its Debt Responsibly
Feb 01Is Wooree Bio Co.,Ltd's (KOSDAQ:082850) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Jan 12Wooree BioLtd (KOSDAQ:082850) Shareholders Have Enjoyed A Whopping 478% Share Price Gain
Dec 21Here's Why We Think Wooree BioLtd's (KOSDAQ:082850) Statutory Earnings Might Be Conservative
Nov 29Financial Position Analysis
Short Term Liabilities: A082850's short term assets (₩460.6B) exceed its short term liabilities (₩322.5B).
Long Term Liabilities: A082850's short term assets (₩460.6B) exceed its long term liabilities (₩54.8B).
Debt to Equity History and Analysis
Debt Level: A082850 has more cash than its total debt.
Reducing Debt: A082850's debt to equity ratio has reduced from 101.2% to 37.5% over the past 5 years.
Debt Coverage: A082850's debt is well covered by operating cash flow (49%).
Interest Coverage: A082850's interest payments on its debt are well covered by EBIT (19.3x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 01:59 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Wooree Bio Co.,Ltd is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jonathan Rhee | Citigroup Inc |
| Sang Hyeon Park | iM Securities |
| Jong Woo Yoo | Korea Investment & Securities Co., Ltd. |